Why is Vaishali Pharma falling/rising?

As of 12-Sep, Vaishali Pharma Ltd's stock price is currently at 11.96, reflecting a decrease of 0.1, or 0.83%. The stock has underperformed its sector today by 1.12%, and it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 73.41% compared to the 5-day average. The stock has shown a concerning trend over the past year, with a return of -42.15%, and has consistently underperformed against the BSE500 index in both the short and long term. The company's weak long-term fundamentals, including a -145.73% CAGR growth in operating profits over the last five years and a negative EBITDA, further contribute to its declining stock price.
In the broader market context, the Sensex has increased by 1.51% over the past week, while Vaishali Pharma's stock has only risen by 0.42% in the same period, indicating a significant underperformance relative to the benchmark. This trend is compounded by the company's weak financial health, as evidenced by a poor EBIT to interest ratio of 1.68 and a low return on equity of 7.89%. The flat results reported in June, with a PAT decline of 24.7%, alongside the overall negative sentiment surrounding the stock, suggest that investors are cautious, leading to a lack of confidence and further declines in the stock price.